Ritodrine
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391737This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0Q6O6740J. European Medicines Agency schedules Ritodrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10340MIG. Ritodrine generally arises in the molecular formula C17H21NO3. The term RITODRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, no. 11 1970, list 10.) RITODRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ritodrine under HS 29394900 and SITC 54144. As of Q4 2014, RITODRINE remains the US FDA Preferred Term for this commodity. Ritodrine bears US NLM identifiers UMLS ID C0035661 and NCI Concept Code C61929. SMILES: OC(C(NCCC1CCC(O)CC1)C)C1CCC(O)CC1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.